Suppr超能文献

Notch信号通路在肾细胞癌中对癌症干细胞维持干性和介导趋化性起着关键作用。

Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.

作者信息

Xiao Wei, Gao Zhiyong, Duan Yixing, Yuan Wuxiong, Ke Yang

机构信息

Department of Urology, Hunan Provincial People's Hospital, JiefangWest Road 61, Changsha, Hunan, China.

出版信息

J Exp Clin Cancer Res. 2017 Mar 9;36(1):41. doi: 10.1186/s13046-017-0507-3.

Abstract

BACKGROUND

Cancer stem cells (CSCs) are correlated with the initiation, chemoresistance and relapse of tumors. Notch pathway has been reported to function in CSCs maintenance, but whether it is involved in renal cell carcinoma (RCC) CSCs maintaining stemness remain unclear. This study aims to explore the effect of Notch pathway on stemness of CSCs in RCC and the underlying mechanisms.

METHODS

The CD133/CD24 cells were isolated from RCC ACHN and Caki-1 cell line using Magnetic-activated cell sorting and identified by Flow cytometry analysis. RT-PCR and immunoblot analyses were used for determining the stemness maker expression. The effect of Notch pathway on function of CSCs was assessed by self-renewal ability, chemosensitivity, invasive and migratory ability tumorigenicity in vivo using soft agar colony formation assay, sphere-forming assay, MTT assay, Transwell assay.

RESULTS

Here, we found that the sorted CD133/CD24cells possessed elevated stemness maker CTR2, BCL-2, MDR1, OCT-4, KLF4, compared with parental cells, as well as enhanced self-renewal ability, stronger resistance to cisplatin and sorafenib, increased invasion and migration, and higher tumorigenesis in vivo, suggesting the CD133/CD24 cells have the stem-like characteristics of CSCs and thus identified as RCC CSCs. Then the enhanced notch1, notch2, Jagged1, Jagged2, DLL1 and DLL4 expression were detected in RCC CSCs and blockage of Notch1 or notch2 using pharmacological inhibitor MRK-003 or its endogenous inhibitor Numb resulted in loss of its stemness features: self-renewal, chemoresistance, invasive and migratory potential, and tumorigenesis in vivo. Moreover, it is confirmed that overexpression of notch1 up-regulated CXCR4 inRCC CSCs and augmented SDF-1-induced chemotaxis in RCC CSCs in vitro, which could be rescued when treatment of CXCR4 inhibitor, suggesting that notch signaling promotes the chemotaxis of RCC CSCs by SDF-1/CXCR4 axis.

CONCLUSIONS

Our results provide a new mechanism of RCC CSCs maintaining stemness via notch pathway as well as a potential therapeutic target in human RCC.

摘要

背景

癌症干细胞(CSCs)与肿瘤的发生、化疗耐药及复发相关。据报道,Notch信号通路在维持CSCs干性中发挥作用,但它是否参与肾细胞癌(RCC)CSCs干性的维持仍不清楚。本研究旨在探讨Notch信号通路对RCC中CSCs干性的影响及其潜在机制。

方法

采用磁珠分选法从RCC ACHN和Caki-1细胞系中分离出CD133/CD24细胞,并用流式细胞术分析进行鉴定。采用RT-PCR和免疫印迹分析来测定干性标志物的表达。通过软琼脂集落形成试验、成球试验、MTT试验、Transwell试验,从自我更新能力、化学敏感性、侵袭和迁移能力、体内致瘤性等方面评估Notch信号通路对CSCs功能的影响。

结果

在此,我们发现分选得到的CD133/CD24细胞与亲本细胞相比,干性标志物CTR2、BCL-2、MDR1、OCT-4、KLF4表达升高,自我更新能力增强,对顺铂和索拉非尼的耐药性更强,侵袭和迁移能力增强,体内致瘤性更高,表明CD133/CD24细胞具有CSCs的干细胞样特征,因此被鉴定为RCC CSCs。然后,在RCC CSCs中检测到Notch1、Notch2、Jagged1、Jagged2、DLL1和DLL4表达增强,使用药理学抑制剂MRK-003或其内源抑制剂Numb阻断Notch1或Notch2会导致其干细胞特征丧失:自我更新、化疗耐药、侵袭和迁移潜能以及体内致瘤性。此外,证实Notch1的过表达上调了RCC CSCs中CXCR4的表达,并增强了RCC CSCs在体外对SDF-1诱导的趋化作用,当用CXCR4抑制剂处理时这种作用可被挽救,表明Notch信号通过SDF-1/CXCR4轴促进RCC CSCs的趋化作用。

结论

我们的结果揭示了RCC CSCs通过Notch信号通路维持干性的新机制,以及人类RCC的一个潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0285/5345133/8d9b98c3029c/13046_2017_507_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验